Breast cancer type linked to paternal cancer

The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's open access journal BMC Cancer looked at the relationship between women with breast cancer and diagnosis of cancer in their parents. The results showed that the chances of women with lobular breast cancer having a father with cancer (especially prostate cancer) was almost twice as likely as women with other forms of breast cancer.

Researchers from Lund University looked at the family history, pathology reports and hospital records for women diagnosed with between 1980 and 2008. About 40% of the women had invasive ductal breast cancer and 8% had lobular cancer. At diagnosis, 15% of all these women had a father with cancer and 21% had a mother already diagnosed with cancer.

Once the data was adjusted for age, use of HRT, number of children, and known genetic factors, such as having a mother with breast cancer, a woman having a father with cancer almost doubled the risk of having lobular cancer, when compared to any other type of breast cancer.

Since breast cancer is often hormonally driven (in this study 63% of women with lobular cancer were estrogen receptor positive), it might be assumed that the type of cancer the father had could be important. However the increase in risk of lobular breast cancer due to having a father with cancer was independent of both estrogen receptor and progesterone receptor status. Prostate cancer is also often hormonally driven but the link between lobular cancer and a father with cancer remained even after removing the group of fathers with from the analysis.

Carolina Ellberg who performed this research explained, "We also looked at grandparents and other family members, but the increased risk of lobular cancer was directly linked to having a father with cancer. This does not necessarily mean that the daughter of a man diagnosed with cancer is more likely to get lobular breast cancer - it means that if she develops breast cancer it is more likely to be lobular."

add to favorites email to friend print save as pdf

Related Stories

Hormone therapy raises cancer risk

Jan 16, 2008

Menopausal women who take hormone combinations for their symptoms are more likely to get an uncommon type of breast cancer much earlier than experts believed.

Alcohol intake increases certain types of breast cancer

Aug 23, 2010

Alcohol increases the risk of lobular and hormone receptor-positive breast cancer, but not necessarily invasive ductal carcinomas, according to a study published August 23 online in The Journal of the National Cancer Institute.

Recommended for you

Renewed hope in a once-abandoned cancer drug class

3 hours ago

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

Finding the way to lung tumours by 'GPS'

4 hours ago

The innumerable divisions of the bronchi often turn the hunt for tumours in the lungs into a game of chance. But soon, lung specialists will be able to navigate accurately inside the airways by "GPS".

Study suggests new approach to fight lung cancer

19 hours ago

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.